Boston Scientific reports that its 4th-quarter profits slid 19% but still managed to beat expectations on Wall Street.
(Reuters) — Medical device maker Boston Scientific (NYSE:BSX) posted a 19% fall in fourth-quarter profit as litigation charges more than doubled.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zfcV3K
Cap comentari:
Publica un comentari a l'entrada